David Redfern

David Redfern is a declared insider of GSK plc, with filings sourced from RNS (LSE). The record holds 126 filings, for trades running from 9 August 2023 to 12 October 2026.

Both buying and selling appear: 1 purchase, against 8 sales worth €9.2M. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 117 share grants. So far in 2026, the count stands at 1 purchase and 3 sales.

On 14 October 2026 came the latest disclosure, a share grant for €18k in GSK plc. The last purchase on record was published on 13 January 2026, which is 277 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 3 days. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.